HomeYPH • FRA
add
Astellas Pharma Inc
Nakaraang pagsara
€9.56
Sakop ng araw
€9.38 - €9.68
Sakop ng taon
€7.53 - €10.53
Market cap
3.17T JPY
Average na Volume
80.00
P/E ratio
-
Dividend yield
-
Primary exchange
TYO
Mga balita tungkol sa merkado
Mga Financial
Income Statement
Kita
Net na kita
| (JPY) | Set 2025info | Y/Y na pagbabago |
|---|---|---|
Kita | 524.32B | 13.37% |
Gastos sa pagpapatakbo | 325.88B | -4.65% |
Net na kita | 79.21B | 120.60% |
Net profit margin | 15.11 | 94.72% |
Kita sa bawat share | — | — |
EBITDA | 140.20B | 59.23% |
Aktuwal na % ng binabayarang buwis | 23.97% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (JPY) | Set 2025info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 287.05B | -2.03% |
Kabuuang asset | 3.45T | -0.35% |
Kabuuang sagutin | 1.84T | -4.89% |
Kabuuang equity | 1.61T | — |
Natitirang share | 1.79B | — |
Presyo para makapag-book | 0.01 | — |
Return on assets | 6.85% | — |
Return on capital | 9.83% | — |
Cash Flow
Net change in cash
| (JPY) | Set 2025info | Y/Y na pagbabago |
|---|---|---|
Net na kita | 79.21B | 120.60% |
Cash mula sa mga operasyon | 227.76B | 251.42% |
Cash mula sa pag-invest | -13.46B | 17.87% |
Cash mula sa financing | -144.75B | -166.37% |
Net change in cash | 71.66B | 821.24% |
Malayang cash flow | 195.05B | 347.45% |
Tungkol
Astellas Pharma Inc. is a Japanese multinational pharmaceutical company, formed on 1 April 2005 from the merger of Yamanouchi Pharmaceutical Co., Ltd. and Fujisawa Pharmaceutical Co., Ltd.
Astellas is a member of the Mitsubishi UFJ Financial Group keiretsu. Wikipedia
Itinatag
Abr 1, 2005
Headquarters
Website
Mga Empleyado
13,643
